How safe is natalizumab during pregnancy?

被引：6

作者：

Duquette, Pierre ^{[1
]}

Prat, Alexandre ^{[2
]}

机构：

[1] CHUM Notre Dame, Montreal, PQ H2L 4M1, Canada

[2] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada

来源：

MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷 / 02期

关键词：

MULTIPLE-SCLEROSIS;

D O I：

10.1177/1352458514555789

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：121 / 122

页数：2

共 11 条

[1] Rate of pregnancy-related relapse in multiple sclerosis [J].

Confavreux, C ;

Hutchinson, M ;

Hours, MM ;

Cortinovis-Tourniaire, P ;

Moreau, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :285-291

[2]

Ebrahimi N, 2014, MULT SCLER

[3] Normal outcome of pregnancy with ongoing treatment with natalizumab [J].

Fagius, J. ;

Burman, J. .

ACTA NEUROLOGICA SCANDINAVICA, 2014, 129 (06) :E27-E29

[4] Natalizumab Use During the Third trimester of Pregnancy [J].

Haghikia, Aiden ;

Langer-Gould, Annette ;

Rellensmann, Georg ;

Schneider, Henriette ;

Tenenbaum, Tobias ;

Elias-Hamp, Birte ;

Menck, Sylvia ;

Zimmermann, Julian ;

Herbstritt, Sandra ;

Marziniak, Martin ;

Kuempfel, Tania ;

Meinl, Ingrid ;

Plavina, Tatiana ;

Gold, Ralf ;

Hellwig, Kerstin .

JAMA NEUROLOGY, 2014, 71 (07) :891-895

[5] Bridging, switching or drug holidays - how to treat a patient who stops natalizumab? [J].

Havla, Joachim ;

Kleiter, Ingo ;

Kuempfel, Tania .

THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2013, 9 :361-369

[6] Fingolimod after natalizumab and the risk of short-term relapse [J].

Jokubaitis, Vilija G. ;

Li, Vivien ;

Kalincik, Tomas ;

Izquierdo, Guillermo ;

Hodgkinson, Suzanne ;

Alroughani, Raed ;

Lechner-Scott, Jeannette ;

Lugaresi, Alessandra ;

Duquette, Pierre ;

Girard, Marc ;

Barnett, Michael ;

Grand'Maison, Francois ;

Trojano, Maria ;

Slee, Mark ;

Giuliani, Giorgio ;

Shaw, Cameron ;

Boz, Cavit ;

Spitaleri, Daniele L. A. ;

Verheul, Freek ;

Haartsen, Jodi ;

Liew, Danny ;

Butzkueven, Helmut .

NEUROLOGY, 2014, 82 (14) :1204-1211

[7] Does pregnancy alter the long-term course of multiple sclerosis? [J].

Karp, Igor ;

Manganas, Alexandra ;

Sylvestre, Marie-Pierre ;

Ho, Annie ;

Roger, Elaine ;

Duquette, Pierre .

ANNALS OF EPIDEMIOLOGY, 2014, 24 (07) :504-508

[8] Disease-modifying drugs for multiple sclerosis in pregnancy A systematic review [J].

Lu, Ellen ;

Wang, Bing Wei ;

Guimond, Colleen ;

Synnes, Anne ;

Sadovnick, Dessa ;

Tremlett, Helen .

NEUROLOGY, 2012, 79 (11) :1130-1135

[9] LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL [J].

Rigau, Valerie ;

Mania, Alexandre ;

Befort, Patrice ;

Carlander, Bertrand ;

Jonquet, Olivier ;

Lassmann, Hans ;

Camu, William ;

Thouvenot, Eric .

NEUROLOGY, 2012, 79 (22) :2214-2216

[10] What to expect after natalizumab cessation in a real-life setting [J].

Salhofer-Polanyi, S. ;

Baumgartner, A. ;

Kraus, J. ;

Maida, E. ;

Schmied, M. ;

Leutmezer, F. .

ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (02) :97-102

← 1 2 →